YU51401A - Postupak za dobijanje n6-supstituisanih derivata deaza-adenozima - Google Patents

Postupak za dobijanje n6-supstituisanih derivata deaza-adenozima

Info

Publication number
YU51401A
YU51401A YU51401A YU51401A YU51401A YU 51401 A YU51401 A YU 51401A YU 51401 A YU51401 A YU 51401A YU 51401 A YU51401 A YU 51401A YU 51401 A YU51401 A YU 51401A
Authority
YU
Yugoslavia
Prior art keywords
preparing
adenosine derivatives
substituted
deaza
substituted deaza
Prior art date
Application number
YU51401A
Other languages
English (en)
Inventor
Diane C. Salazar
Original Assignee
Aventis Pharmaceuticals Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Products Inc. filed Critical Aventis Pharmaceuticals Products Inc.
Publication of YU51401A publication Critical patent/YU51401A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Ovaj pronalazak se odnosi na poboljšan postupak za dobijanje N6-supstituisanih derivata adenosina, na njihove upotrebljive medjuproizvode i postupke za dobijanje tih medjuproizvoda.[This invention is directed to improved methods for preparing N6-substituted adenosine derivatives, to intermediates useful therefor and to methods of preparing these intermediates.
YU51401A 1998-12-21 1999-12-14 Postupak za dobijanje n6-supstituisanih derivata deaza-adenozima YU51401A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11307798P 1998-12-21 1998-12-21

Publications (1)

Publication Number Publication Date
YU51401A true YU51401A (sh) 2003-12-31

Family

ID=22347487

Family Applications (1)

Application Number Title Priority Date Filing Date
YU51401A YU51401A (sh) 1998-12-21 1999-12-14 Postupak za dobijanje n6-supstituisanih derivata deaza-adenozima

Country Status (28)

Country Link
US (1) US6184382B1 (sh)
EP (1) EP1175420B1 (sh)
JP (1) JP2002533343A (sh)
KR (1) KR20010087425A (sh)
CN (1) CN1122667C (sh)
AP (1) AP1336A (sh)
AT (1) ATE235493T1 (sh)
AU (1) AU774155B2 (sh)
BG (1) BG105624A (sh)
BR (1) BR9917088A (sh)
CA (1) CA2357760A1 (sh)
CZ (1) CZ20012283A3 (sh)
DE (1) DE69906392T2 (sh)
DK (1) DK1175420T3 (sh)
EA (1) EA003645B1 (sh)
EE (1) EE200100333A (sh)
ES (1) ES2191489T3 (sh)
HK (1) HK1041607A1 (sh)
HU (1) HUP0105224A3 (sh)
ID (1) ID30118A (sh)
IL (1) IL143843A0 (sh)
NO (1) NO319789B1 (sh)
NZ (1) NZ512500A (sh)
PL (1) PL349154A1 (sh)
PT (1) PT1175420E (sh)
SK (1) SK284767B6 (sh)
WO (1) WO2000037469A2 (sh)
YU (1) YU51401A (sh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9713705A (pt) * 1996-12-11 2000-05-09 Rhone Poulenc Rorer Pharma Composto, e, processo para a preparação do mesmo
KR100446669B1 (ko) * 2002-04-04 2004-09-04 (주) 비엔씨바이오팜 2-(헤테로사이클릭-알킬아미노)피리딘 유도체, 그제조방법 및 이를 포함하는 항바이러스용 약학적 조성물
US7291603B2 (en) * 2002-07-24 2007-11-06 Ptc Therapeutics, Inc. Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652366A (en) * 1990-09-25 1997-07-29 Rhone-Poulenc Rorer Pharmaceuticals Inc. DI (1R)-(-)camphosulfonic acid) salt, preparation thereof and use thereof
US5561134A (en) * 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
WO1992005177A1 (en) * 1990-09-25 1992-04-02 Rhone-Poulenc Rorer International (Holdings) Inc. Compounds having antihypertensive and anti-ischemic properties

Also Published As

Publication number Publication date
AP1336A (en) 2004-11-30
SK9072001A3 (en) 2001-12-03
IL143843A0 (en) 2002-04-21
WO2000037469A2 (en) 2000-06-29
AU774155B2 (en) 2004-06-17
NO20013044L (no) 2001-08-20
DE69906392D1 (de) 2003-04-30
HUP0105224A3 (en) 2003-01-28
CA2357760A1 (en) 2000-06-29
ATE235493T1 (de) 2003-04-15
PT1175420E (pt) 2003-08-29
EE200100333A (et) 2002-08-15
AP2001002200A0 (en) 2001-09-30
SK284767B6 (sk) 2005-11-03
DK1175420T3 (da) 2003-07-07
EA200100697A1 (ru) 2001-12-24
NO319789B1 (no) 2005-09-12
HK1041607A1 (zh) 2002-07-12
CZ20012283A3 (cs) 2001-10-17
EP1175420A2 (en) 2002-01-30
ES2191489T3 (es) 2003-09-01
BG105624A (en) 2002-01-31
NO20013044D0 (no) 2001-06-19
WO2000037469B1 (en) 2000-11-02
PL349154A1 (en) 2002-07-01
CN1122667C (zh) 2003-10-01
ID30118A (id) 2001-11-08
NZ512500A (en) 2003-01-31
DE69906392T2 (de) 2004-02-05
EA003645B1 (ru) 2003-08-28
CN1333773A (zh) 2002-01-30
BR9917088A (pt) 2006-01-31
HUP0105224A2 (en) 2002-06-29
AU2181400A (en) 2000-07-12
US6184382B1 (en) 2001-02-06
KR20010087425A (ko) 2001-09-15
WO2000037469A3 (en) 2000-09-14
JP2002533343A (ja) 2002-10-08
EP1175420B1 (en) 2003-03-26

Similar Documents

Publication Publication Date Title
AU2489197A (en) Carbocyclic intermediates and process of manufacture thereof
ATE506372T1 (de) Verfahren zur herstellung von nukleosidderivate
AU4015697A (en) Bicyclic pyrimidine derivatives and their use as anti-coagulants
CY2522B1 (en) 2-Substituted nucleosides and oligonucleotide derivatives
TR200003036T2 (tr) 12,13-Modifiye edilmiş epotilon türevleri
HK1032746A1 (en) Bridged indenopyrrolocarbazoles.
BG105009A (en) Method for producing 4-carboxyamino-2-substituted 1,2,3,4-tetrahydroquinoline
HK1040239A1 (en) Process for preparing N6-substituted deaza-adenosine derivatives.
UA6044A1 (uk) Спосіб одержання метіленових похідних андроста-1,4 -діен-3,17-діона
JO2252B1 (en) Method for preparing pyridine derivatives
HK1034512A1 (en) Process for the production of purine derivatives and intermediates therefor
YU51401A (sh) Postupak za dobijanje n6-supstituisanih derivata deaza-adenozima
HK1037368A1 (en) Process for the synthesis of (1h)-benzo[c]quinolizin-3-ones derivatives
EP0948512A4 (en) METHOD FOR SYNTHESIZING OLIGONUCLEOTIDES PHOSPHOROTHIOATES
TWI265923B (en) Process for the preparation of 3-acylated indoles
NO20052327L (no) Fremgangsmate ved fremstilling av [3aR-[3aa,4a,6a(R*), 6aa]]-6-[[3-amino-4-[[l-[(3-klor-2-tienyl)metyl]propyl]amino]-2-pyridinyl]amino]-N-etyltetrahydro-2,2-dimetyl-4H-cyklopenta-1,3-dioksol-4-karboksamid
CZ20011915A3 (cs) Způsob výroby cyklenu
PL322503A1 (en) Method of obtaining nucleoside analoques
UA81595C2 (en) Process for the purification of carboxaldehyde
EA199801007A1 (ru) Способ биосинтеза, позволяющий получать кобаламины
IL146257A0 (en) Method of producing methoxyimido acetic amide
MY127539A (en) Bridged indenopyrrolocarbazoles